Sds Optic Spolka Akcyjna Logo

Sds Optic Spolka Akcyjna

Develops diagnostic solutions, custom antibodies, and optical coatings.

SDS | WAR

Overview

Corporate Details

ISIN(s):
PLSDSOP00013 (+3 more)
LEI:
259400G9MUCF7RQLHQ45
Country:
Poland
Address:
LUBLIN GŁĘBOKA 39, 20-612 LUBLIN

Description

Sds Optic Spolka Akcyjna is a biotechnology company that develops diagnostic solutions for oncology and infectious diseases. Its flagship technology, inPROBE®, is a fiber-optic microsensor that combines photonics and molecular biology for the real-time, point-of-care detection of cancer biomarkers, such as HER2 expression. This platform is designed to complement existing diagnostic methods to improve access to targeted therapies. In addition to its diagnostic focus, the company provides custom antibody development and small-scale manufacturing services, including monoclonal and anti-idiotype antibodies. Sds Optic also offers advanced optical coating solutions using nanolayer technology to enhance the performance and durability of lenses for the optics, electronics, and medical device industries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-11 18:09
Podpisanie aneksu do umowy dofinansowania z Lubelską Agencją Wspierania Przedsi…
Polish 1.3 KB
2024-05-13 17:54
Zawiadomienie na podstawie art. 69 UoO - SDS Optonic
Polish 77.4 KB
2024-05-13 17:54
Zawiadomienie o zmianie udziału w ogólnej liczbie głosów na Walnym Zgromadzeniu…
Polish 1.2 KB
2024-03-29 11:09
zal01_Powiadomienie_art.19_MAR_-_Damian_Serafin.pdf
Polish 5.9 KB
2024-03-29 11:09
Informacja o transakcjach dokonanych przez Członka Rady Nadzorczej - Content (P…
Polish 488 bytes
2024-03-07 12:29
Otrzymanie środków z Transzy A w ramach umowy finansowania zawartej z Europejsk…
Polish 1.6 KB
2024-03-04 12:08
zal02_2.Powiadomienie_art.19_MAR_-_Magdalena_Staniszewska.pdf
Polish 4.4 KB
2024-03-04 12:08
zal01_1.Powiadomienie_art.19_MAR_-_Marcin_Staniszewski.pdf
Polish 4.4 KB
2024-03-04 12:08
Informacja o transakcjach dokonanych przez osobę pełniącą obowiązki zarządcze o…
Polish 666 bytes
2024-02-29 12:16
Przydział warrantów subskrypcyjnych serii A osobom uprawnionym w ramach Program…
Polish 2.0 KB
2024-02-08 15:30
Przydział warrantów subskrypcyjnych serii B na rzecz Europejskiego Banku Inwest…
Polish 2.0 KB
2024-01-29 14:42
Pozytywne wyniki pierwszej części badania klinicznego mikrosondy inPROBE stosow…
Polish 7.2 KB
2024-01-16 11:33
Realizacja kamienia milowego w postaci podpisania umowy wynajmu centrum R_D w S…
Polish 4.8 KB
2024-01-05 11:27
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym…
Polish 1.0 KB
2024-01-05 11:18
zal01_Zalacznik_Nr_1._Uchwaly_podjete_na_Nadzwyczajnym_Walnym_Zgromadzeniu_Akcj…
Polish 345.6 KB

Automate Your Workflow. Get a real-time feed of all Sds Optic Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sds Optic Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sds Optic Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aptahem AB Logo
A clinical-stage biotech developing aptamer-based drugs for life-threatening conditions.
Sweden
APTA
APTAMER GROUP PLC Logo
Develops custom affinity binders for research, diagnostics, and therapeutics.
United Kingdom
APTA
Aptevo Therapeutics Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for cancer.
United States of America
APVO
Biotech firm providing MICROPIG models, bio-resources, and non-clinical CRO services.
South Korea
149300
Aran Research & Development (1982) Ltd. Logo
A product design and development firm providing services from concept to manufacturing.
Israel
ARAN
Artiva Biotherapeutics, Inc. Logo
Develops allogeneic, off-the-shelf NK cell therapies for cancer and autoimmune diseases.
United States of America
ARTV
ARVINAS, INC. Logo
Clinical-stage biopharma developing therapeutics based on targeted protein degradation.
United States of America
ARVN
Asarina Pharma AB Logo
A biotechnology company in liquidation, formerly focused on neurosteroid therapies.
Sweden
ASAP
Atara Biotherapeutics, Inc. Logo
Develops off-the-shelf allogeneic T-cell immunotherapies for cancer and autoimmune diseases.
United States of America
ATRA
An integrated biologics development partner offering services from DNA sequence to cell bank.
South Korea
355690

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.